Related Experiment Video
Updated: Aug 8, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Fine-needle aspiration of chondrosarcoma
1Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA. leslie.dodd@duke.edu
Diagnostic Cytopathology
|May 9, 2006
Summary
Fine-needle aspiration (FNA) is accurate for diagnosing recurrent chondrosarcoma (CS) but less so for primary bone tumors. Sampling issues can affect the accuracy of FNA for primary CS.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Fine-needle aspiration (FNA) is a common diagnostic tool for solid tissue neoplasms.
- Its utility in diagnosing primary bone tumors, specifically chondrosarcoma (CS), remains debated.
Purpose of the Study:
- To evaluate the diagnostic accuracy and limitations of FNA for chondrosarcoma (CS).
- To determine the appropriate role of FNA in the diagnosis of primary, recurrent, and metastatic CS.
Main Methods:
- Retrospective review of institutional records for patients diagnosed and treated for CS between 1993 and 2003.
- Analysis of FNA cytology and subsequent histological confirmation for 32 patients with CS.
- Image-guided FNA was predominantly used, with standard methods for palpable lesions.
Main Results:
- Diagnostic accuracy of FNA for primary CS was 67% (18/27).
- Accuracy for recurrent or metastatic CS was higher at 86% (6/7).
- False negatives in primary CS were attributed to inadequate sampling; misdiagnosis occurred with chondroblastic osteosarcoma.
Conclusions:
- FNA is a reliable diagnostic method for recurrent and metastatic chondrosarcoma (CS) in patients with a known history.
- The accuracy of FNA for primary bone chondrosarcoma (CS) is limited, with sampling difficulties and potential for misdiagnosis.
- Further evaluation is needed to optimize FNA's role in primary CS diagnosis.
